This forum is for the discussion of anything to do with Prostate Cancer. There are only four rules:
No fundraisers, no commercials (although it is OK to recommend choices of treatment or medical people based on your personal research; invitations to participate in third-party surveys are also acceptable, provided there is no compensation to YANA);
No harvesting e-mail addresses for Spam;
No insults or flaming - be polite and respectful at all times and understand that there may be a variety of points of view, all of which may have some validity;
Opinions are OK, but please provide as much factual evidence as possible for any assertions that you are making
Failure to abide by these simple rules will result in the immediate and permanent suspension of your posting privileges.
Since this is an International Forum, please specify your location in your post.
Re: ProstaVysion - a genetic test for determining tumor aggressiveness
Interesting, Alan, please keep us informed.
I am less convinced than you are about the value of this test, which, as far as I can see has not been subjected to any peer review. In the fifteen years I have been on AS (Active Surveillance) I have seen many claims made by individual organisations, but few of these claims have proved to be valid when subject to objective scrutiny.
I have not read all the studies referred to in the Bostwick page but those I have read are not exactly conclusive, referring to associations between the various tests and potential outcomes. Association is not proof.
I don’t have time right now to read all the references, but perhaps someone else might and summarise the relevance of these small studies?
